This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Community Health Systems (CYH) Q3 Earnings Preview: What to Look Out For
by Zacks Equity Research
Community Health Systems (CYH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Community Health Divests Unit to Focus on Core Business
by Zacks Equity Research
Community Health (CYH) completes the pending sale of 238-bed AllianceHealth Deaconess hospital to lower debts and concentrate more on core business.
Implied Volatility Surging for Community Health (CYH) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Community Health (CYH) stock based on the movements in the options market lately.
Community Health's (CYH) Ratings Downgraded, Outlook Stable
by Zacks Equity Research
Moody's Investors Service downgrades Community Health's (CYH) ratings. Outlook for the same is stable.
Community Health's (CYH) Subsidiary to Clear Fraud Charges
by Zacks Equity Research
Community Health Systems' (CYH) arm to settle whistleblower lawsuits alleging a wide-ranging misconduct in emergency rooms.
Will Hurricane Florence Hurt LifePoint's Patient Volumes?
by Zacks Equity Research
LifePoint's (LPNT) exposure to Carolina might lead to decline in patient visits, possibly hurting business volumes.
Is the Options Market Predicting a Spike in Community Health (CYH) Stock?
by Zacks Equity Research
Investors need to pay close attention to Community Health (CYH) stock based on the movements in the options market lately.
Community Health (CYH) Incurs Lower Loss Than Expected in Q2
by Zacks Equity Research
Community Health's (CYH) Q2 results suffer loss from decline in admissions.
Implied Volatility Surging for Community Health (CYH) Stock Options
by Zacks Equity Research
Community Health (CYH) needs investors to pay close attention to the stock based on moves in the options market lately.
Community Health Arm to Divest AllianceHealth Deaconess
by Zacks Equity Research
Community Health (CYH) subsidiary to sell AllianceHealth Deaconess hospital in Oklahoma City to INTEGRIS Health's unit.
Community Health's Ratings Downgraded by Moody's
by Zacks Equity Research
Moody's downgrades the ratings of Community Health (CYH). The outlook of the company stays stable.
Community Health (CYH) Up 8.3% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Community Health (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Community Health (CYH) Posts Earnings in Q1, Revenues Top
by Zacks Equity Research
Community Health's (CYH) Q1reflects expansion in transfer and access program, launch of Accountable Care Organizations, and investments in outpatient capabilities and service line. However, admissions declined.
Implied Volatility Surging for Community Health (CYH) Stock Options
by Zacks Equity Research
Community Health (CYH) needs investors to pay close attention to the stock based on moves in the options market lately.
Why did Community Health Stock Sink More Than 50% in a Year?
by Zacks Equity Research
Community Health (CYH) underperforms the industry due to rising expenses, ailing revenues and a weak guidance.
Tenet Healthcare Sells MacNeal Hospital to Streamline Trade
by Zacks Equity Research
Tenet Healthcare's (THC) divestitures aim at debt repayment, reduction of interest burden and streamlining of core business.
Options Traders Expect Huge Moves in Community Health (CYH) Stock
by Zacks Equity Research
Investors in Community Health (CYH) need to pay close attention to the stock based on moves in the options market lately.
Can Revenue Rise Aid Envision Healthcare (EVHC) Q4 Earnings?
by Zacks Equity Research
Envision Healthcare (EVHC) Q4 earnings might see an upside from higher revenues in Physician Services segment, partly offset by high expenses and lower revenues from Ambulatory Service segment.
Will Higher Revenues Buoy Teladoc's (TDOC) Q4 Earnings?
by Zacks Equity Research
Teladoc's (TDOC) fourth-quarter 2017 results to benefit from an increase in members utilizing its services, higher visits and growing client roaster.
Will Lower Volume Hurt Tenet Healthcare's (THC) Q4 Earnings?
by Zacks Equity Research
Industry-wide softness in admissions might affect Tenet Healthcare's (THC) fourth-quarter results.
Is a Surprise Coming for Community Health (CYH) This Earnings Season?
by Zacks Equity Research
Given that Community Health (CYH) has a Zacks Rank #3 (Hold) and an ESP in positive territory, investors might want to consider this stock ahead of earnings.
4 Health Care Stocks Set to Beat Earnings Estimates in 4Q
by Zacks Equity Research
This attractive sector has several companies with upside potential.
Can Solid Medicaid Business Boost Centene (CNC) Q4 Earnings?
by Zacks Equity Research
Centene's (CNC) fourth-quarter results are expected to be supported by membership growth and cost-saving initiatives.
HCA Healthcare's Top Line Grows on Buyouts, Bad Debts Hurt
by Zacks Equity Research
Although HCA Healthcare's (HCA) top line continues to grow on the back of admissions, industry wide softness in volume, political uncertainty and high bad debt bother.
Options Traders Expect Huge Moves in Community Health (CYH) Stock
by Zacks Equity Research
Surging implied volatility makes Community Health (CYH) stock lucrative to the option traders.